{"id":"W2756935441","doi":"10.1158/1535-7163.mct-17-0170","title":"Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Olaparib; PARP inhibitor; Veliparib; Breast cancer; Cancer research; Triple-negative breast cancer; Cancer; Gene signature; Biology; DNA damage; Poly ADP ribose polymerase; Medicine; Molecular biology; Oncology; Internal medicine; Gene expression; Gene; Genetics; DNA","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000130342,0.0002220062,0.0003242207,0.0007013601,0.000177325,0.0002948702,0.00009639419,0.0001746392,0.0007210273],"category_scores_gemma":[0.0002571209,0.00007705288,0.0002264238,0.0006521341,0.000113896,0.00008340843,0.0001754099,0.0001891423,0.0001885264],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002026433,"about_ca_system_score_gemma":0.000209526,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009187502,"about_ca_topic_score_gemma":0.001195796,"domain_scores_codex":[0.9999002,0.00001516205,0.000007534189,0.00002681674,0.0000245984,0.0000257072],"domain_scores_gemma":[0.9998461,0.00003738696,0.00005682582,0.000009531916,0.00002411311,0.0000260386],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001508201,0.000138525,0.302156,0.0002420458,0.000175809,0.0005678906,0.00009836677,0.00243648,0.672593,0.00009143851,0.0005094057,0.01948292],"study_design_scores_gemma":[0.00002873287,0.0003399613,0.9294523,0.00002207263,0.0001805876,0.001334713,0.0001901264,0.008252598,0.05863294,0.0002902518,0.001257342,0.00001838495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963151,0.0005682483,0.0007500842,0.00004372726,0.00000436185,0.00001796404,0.00195849,0.00003186179,0.0003102747],"genre_scores_gemma":[0.9963085,0.0002253814,0.0009875472,0.00003216357,0.000002466597,0.00002851581,0.002169859,0.000004805633,0.0002407478],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009187502,"threshold_uncertainty_score":0.002412081,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02957030360416233,"score_gpt":0.3234081071926166,"score_spread":0.2938378035884543,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}